Article
The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
PLoS neglected tropical diseases - 1 Mar 2019
Juma Dennis W, Muiruri Peninah, Yuhas Krista, John-Stewart Grace, Ottichilo Ronald, Waitumbi John, Singa Benson, Polyak Christina, Kamau Edwin
Abstract excerpt
OBJECTIVE: Cotrimoxazole prevents opportunistic infections including falciparum malaria in HIV-infected individuals but there are concerns of cross-resistance to other antifolate drugs such as sulphadoxine-pyrimethamine (SP). In this study, we investigated the prevalence of antifolate-resistance mutations in Plasmodium falciparum that are associated with SP resistance in HIV-infected individuals on antiretroviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
